Definition: An antimuscarinic agent that inhibits gastric secretion at lower doses than are required to affect gastrointestinal motility, salivary, central nervous system, cardiovascular, ocular, and urinary function. It promotes the healing of duodenal ulcers and due to its cytoprotective action is beneficial in the prevention of duodenal ulcer recurrence. It also potentiates the effect of other antiulcer agents such as CIMETIDINE and RANITIDINE. It is generally well tolerated by patients.
Other names Pirenzepin ratiopharm; Piren basan; LS519; LS 519; Dihydrochloride, Pirenzepine; ratiopharm Brand of Pirenzepine Dihydrochloride; pirenzepin von ct; ct-Arzneimittel Brand of Pirenzepine Dihydrochlori; Ulgescum; Sagitta Brand of Pirenzepine Dihydrochloride; Ulcoprotect; Pyrenzepine; Pirenzepine Dihydrochloride; Pirenzepin-ratiopharm; Pirenzepin; Piren-basan; LS-519; L-S 519; Gastrozepin; Gastrotsepin
otenzepad [ 11-((2-((diethylamino)methyl)-1-piperidinyl)acetyl)-5,11-dihydro-6H-pyrido(2,3-b)(1-4)benzodiazepine-6-one,AF-DX 116,AF-DX-116,AFDX 116 ] cardioselective muscarinic receptor antagonist; structure given in first source